Santiago Arroyo

Director/Board Member chez H. LUNDBECK A/S

Fortune : 971 100 $ au 31/03/2024

64 ans

100 relations

Health Technology

Consumer Services

Health Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Michael Skynner	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	11 ans
Kevin Lee	M	55	BICYCLE THERAPEUTICS PLC PFIZER, INC.	12 ans
Ganesh Venkataraman Kaundinya	M	57	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	4 ans
Amir Faridmoayer	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Jose-Carlos Gutiérrez-Ramos	M	61	BICYCLE THERAPEUTICS PLC PFIZER, INC.	9 ans
Dominique Sirena	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Alistair Milnes	M	50	BICYCLE THERAPEUTICS PLC	3 ans
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 ans
Jim Smith	M	64	PFIZER, INC.	10 ans
Stephen Sands	M	67	BICYCLE THERAPEUTICS PLC	-
Jeremy Levin	M	70	H. LUNDBECK A/S	7 ans
Jeffrey Berkowitz	M	58	H. LUNDBECK A/S	6 ans
Gregory Winter	M	73	BICYCLE THERAPEUTICS PLC	15 ans
Lene Skole-Sørensen	F	65	H. LUNDBECK A/S	9 ans
Helen H. Hobbs	M	71	PFIZER, INC.	13 ans
Joseph Echevarria	M	66	PFIZER, INC.	9 ans
Janice Bourque	F	67	BICYCLE THERAPEUTICS PLC	5 ans
Travis Thompson	M	-	BICYCLE THERAPEUTICS PLC	6 ans
Dorothea Wenzel	M	55	H. LUNDBECK A/S	3 ans
Lars Erik Holmqvist	M	64	H. LUNDBECK A/S	9 ans
Richard Kender	M	68	BICYCLE THERAPEUTICS PLC	5 ans
Shantanu Narayen	M	60	PFIZER, INC.	11 ans
Lars Bang	M	61	H. LUNDBECK A/S	36 ans
Charl van Zyl	M	57	H. LUNDBECK A/S	1 ans
Lasse Skibsbye	M	41	H. LUNDBECK A/S	2 ans
Denis Patrick	M	-	PFIZER, INC.	14 ans
Zafar Qadir	M	-	BICYCLE THERAPEUTICS PLC	4 ans
Sonya Weigle	F	-	MARINUS PHARMACEUTICALS, INC.	3 ans
Thomas Edward Gibbs	M	53	H. LUNDBECK A/S	1 ans
Tarek Samad	M	-	H. LUNDBECK A/S	3 ans
Steve Danehy	M	-	PFIZER, INC.	12 ans
Dorte Clausen	F	40	H. LUNDBECK A/S	2 ans
Hossein Armandi	M	62	H. LUNDBECK A/S	2 ans
Camilla Andersson	F	52	H. LUNDBECK A/S	2 ans
Nicholas Keen	M	56	BICYCLE THERAPEUTICS PLC	7 ans
Thomas Mikkel Mortensen	M	-	H. LUNDBECK A/S	-
Georges Gemayel	M	64	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans
Keld Flintholm Jørgensen	M	53	H. LUNDBECK A/S	5 ans
Monique Schiersing	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
David Borah	M	-	BICYCLE THERAPEUTICS PLC	3 ans
James Sutcliffe	M	68	BICYCLE THERAPEUTICS PLC	1 ans
Pierre Legault	M	63	BICYCLE THERAPEUTICS PLC	5 ans
Palle Holm Olesen	M	-	H. LUNDBECK A/S	-
Graziano Seghezzi	M	55	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Nigel Crockett	M	59	BICYCLE THERAPEUTICS PLC	5 ans
Kush Parmar	M	42	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans
Johan Luthman	M	65	H. LUNDBECK A/S	5 ans
Alethia Young	F	45	BICYCLE THERAPEUTICS PLC	1 ans
Jakob Riis	M	58	H. LUNDBECK A/S	1 ans
Juliane Lenzner	F	-	H. LUNDBECK A/S	-
Ivan Cheung	M	47	EISAI CO., LTD.	19 ans
Jörg Hornstein	M	47	H. LUNDBECK A/S	2 ans
Mira Chaurushiya	M	-	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	-
Philippe Dro	M	61	GlycoEra AG GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020.	2 ans
Jennifer Perry	F	-	BICYCLE THERAPEUTICS PLC	-

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Jeffrey Kindler	M	68	PFIZER, INC.	8 ans
William Steere	M	87	PFIZER, INC.	28 ans
Lee Kalowski	M	43	BICYCLE THERAPEUTICS PLC	6 ans
Deborah Dunsire	M	61	H. LUNDBECK A/S	5 ans
Amy Schulman	F	63	PFIZER, INC.	6 ans
George A. Lorch	M	82	PFIZER, INC.	15 ans
Michael Dougherty	M	66	MARINUS PHARMACEUTICALS, INC.	5 ans
Yi Ning Zhao	M	53	PFIZER, INC.	8 ans
Elise Hauge	F	57	H. LUNDBECK A/S	4 ans
John Mascotte	M	84	PFIZER, INC.	4 ans
Shinji Hatta	M	-	EISAI CO., LTD.	4 ans
Marc Tessier-Lavigne	M	64	PFIZER, INC.	4 ans
Jacob Tolstrup	M	51	H. LUNDBECK A/S	25 ans
Anders Götzsche	M	56	H. LUNDBECK A/S	15 ans
Everett Cunningham	M	57	PFIZER, INC.	9 ans
Robert Landry	M	60	PFIZER, INC.	4 ans
Olivier Brandicourt	M	68	PFIZER, INC.	13 ans
Nicole Vitullo	F	66	MARINUS PHARMACEUTICALS, INC.	17 ans
Veronica Jordan	M	73	BICYCLE THERAPEUTICS PLC	5 ans
Michael Brown	M	82	PFIZER, INC.	16 ans
M. Anthony Burns	M	81	PFIZER, INC.	25 ans
William Herbert Gray	M	82	PFIZER, INC.	13 ans
Robert N. Burt	M	86	PFIZER, INC.	11 ans
Alan Mendelsohn	M	62	PFIZER, INC.	2 ans
David Peritt	M	60	PFIZER, INC.	1 ans
Paulash Mohsen	M	-	PFIZER, INC.	14 ans
Premal Patel	M	54	PFIZER, INC.	2 ans
Margaret Marshall	M	67	PFIZER, INC.	8 ans
Venkat Reddy	M	-	PFIZER, INC.	2 ans
Reina Benabou	M	60	PFIZER, INC.	4 ans
Bhooshitha B. de Silva	M	49	PFIZER, INC.	11 ans
Tanya de Foras	F	53	PFIZER, INC.	10 ans
Hong I. Wan	M	-	PFIZER, INC.	5 ans
Carl Morris	M	54	PFIZER, INC.	5 ans
Soma Gupta	F	-	PFIZER, INC.	6 ans
Adrian Woolfson	M	60	PFIZER, INC.	3 ans
William S. Korinek	M	-	PFIZER, INC.	9 ans
Baiyong Li	M	56	PFIZER, INC.	12 ans
Margaret McLoughlin	M	61	PFIZER, INC.	5 ans
Santhosh Palani	M	41	PFIZER, INC.	3 ans
Valerie Start	M	64	PFIZER, INC.	3 ans
Karen Boykin-Towns	F	59	PFIZER, INC.	4 ans
Nat Ricciardi	M	75	PFIZER, INC.	7 ans
Martine George	M	76	PFIZER, INC.	5 ans
Iain Kilty	M	-	PFIZER, INC.	6 ans

Statistiques

Pays	Relations	% du total
Etats-Unis	48	48,00%
Danemark	25	25,00%
Royaume-Uni	19	19,00%
Suisse	9	9,00%
Japon	2	2,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations

Bourse
Insiders
Santiago Arroyo
Réseau Personnel